Twelve of the 17 adenomas (70%) showed a moderate cytoplasmic staining, four cases (24%) demonstrated weak or negative TARBP2 expression while only one case presented strong TARBP2 immunoreactivity (Fig. 2B and Supplementary Table S2). Here, TARBP2 is linked to adenoma.